Cover Image

Chemosensitizing properties of β-caryophyllene and β-caryophyllene oxide in combination with doxorubicin in human cancer cells

BACKGROUND/AIM: The natural sesquiterpenes β-caryophyllene (CRY) and β-caryophyllene oxide (CRYO) were evaluated for their potential chemosensitizing properties. MATERIALS AND METHODS: CRY and CRYO cytotoxicity was tested against the Caco-2, CCRF/CEM and CEM/ADR5000 human cancer cell lines. Furtherm...

Full description

Saved in:
Bibliographic Details
Main Authors: Di Giacomo, Silvia (Author) , Wink, Michael (Author)
Format: Article (Journal)
Language:English
Published: March 2017
In: Anticancer research
Year: 2017, Volume: 37, Issue: 3, Pages: 1191-1196
ISSN:1791-7530
DOI:10.21873/anticanres.11433
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.21873/anticanres.11433
Get full text
Author Notes:Silvia DI Giacomo, Antonella DI Sotto, Gabriela Mazzanti, Michael Wink
Description
Summary:BACKGROUND/AIM: The natural sesquiterpenes β-caryophyllene (CRY) and β-caryophyllene oxide (CRYO) were evaluated for their potential chemosensitizing properties. MATERIALS AND METHODS: CRY and CRYO cytotoxicity was tested against the Caco-2, CCRF/CEM and CEM/ADR5000 human cancer cell lines. Furthermore, combination experiments were carried out in order to study the ability of the sesquiterpenes to increase doxorubicin cytotoxicity. The possible interference of CRY and CRYO with functionality of ATP-binding cassette (ABC)-transporters was also investigated by Rhodamine123 efflux assay. RESULTS: Despite a low cytotoxicity, both substances were able to enhance the cytotoxicity of doxorubicin in all cell lines, with CRYO being the most effective reversal agent. Both sesquiterpenes were also able to increase the Rho123 content into cells, likely due to inhibition of the efflux pumps. CONCLUSION: Our results highlight a potential role of CRY and CRYO as new chemosensitizing agents for doxorubicin chemotherapy and to re-sensitize cancer-resistant cells.
Item Description:Gesehen am 03.08.2017
Physical Description:Online Resource
ISSN:1791-7530
DOI:10.21873/anticanres.11433

Similar Items